miércoles, 28 de agosto de 2019

Amgen’s R&D chief talks about future of Alzheimer’s research

Amgen’s R&D chief talks about future of Alzheimer’s research

Go West

STAT Plus: Amgen’s R&D chief on the ‘slow-moving tsunami’ of Alzheimer’s and the future of disease research

By MEGAN THIELKING


ALEX HOGAN/STAT
Dr. David Reese, Amgen's head of research and development, spoke with STAT about Alzheimer's research, the amyloid hypothesis, and drug pricing.

No hay comentarios: